Issue 136 • November 2023

Advancing islet transplantation for type 1 diabetes

Diabetes researchers oppose the regulation of islet transplantation as a biologic in the US, following the approval of Lantidra

Briefing

Novartis split complete as Sandoz begins trading on Swiss Exchange

Feature

DCT Tracker: Tracking how sponsors fare at conducting DCTs

Feature

Why are haemophilia gene therapies so expensive?

The Big Interview

Q&A: ‘Trial failure due to recruitment is a thing of the past thanks to AI’